{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:15:38Z","timestamp":1781849738783,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijid.2020.10.103","type":"journal-article","created":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T01:34:20Z","timestamp":1604799260000},"page":"517-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Safety and immunogenicity of co-administration of meningococcal type A and measles\u2013rubella vaccines with typhoid conjugate vaccine in children aged 15\u201323 months in Burkina Faso"],"prefix":"10.1016","volume":"102","author":[{"given":"Sodiomon B.","family":"Sirima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonse","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouhoun","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamadou","family":"Siribie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred B.","family":"Tiono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"N\u00e9bi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amadou T.","family":"Konat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Damoaliga","family":"Berges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amidou","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issiaka","family":"Soulama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5896-4927","authenticated-orcid":false,"given":"Alimatou","family":"Hema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrimati","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Rotrosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kathleen","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie P.","family":"Jamka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3874-581X","authenticated-orcid":false,"given":"Matthew B.","family":"Laurens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2020.10.103_bib0005","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1093\/cid\/civ788","article-title":"A multicountry molecular analysis of salmonella enterica serovar typhi with reduced susceptibility to ciprofloxacin in Sub-Saharan Africa","volume":"62 Suppl 1","author":"Al-Emran","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2020.10.103_bib0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2020.10.103_bib0015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4269\/ajtmh.14-0067","article-title":"Formative investigation of acceptability of typhoid vaccine during a typhoid fever outbreak in Neno District, Malawi","volume":"91","author":"Blum","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.ijid.2020.10.103_bib0020","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.ijid.2020.10.103_bib0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","author":"GBD 2017 Typhoid and Paratyphoid Collaborators","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2020.10.103_bib0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/JCM.02026-14","article-title":"Genomic signature of multidrug-resistant Salmonella enterica serovar typhi isolates related to a massive outbreak in Zambia between 2010 and 2012","volume":"53","author":"Hendriksen","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"10111","key":"10.1016\/j.ijid.2020.10.103_bib0035","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijid.2020.10.103_bib0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12889-016-4002-0","article-title":"A large and persistent outbreak of typhoid fever caused by consuming contaminated water and street-vended beverages: Kampala, Uganda, January\u2013June 2015","volume":"17","author":"Kabwama","year":"2017","journal-title":"BMC Public Health"},{"issue":"Suppl 6","key":"10.1016\/j.ijid.2020.10.103_bib0045","doi-asserted-by":"crossref","first-page":"S499","DOI":"10.1093\/cid\/ciz705","article-title":"Spatial and temporal patterns of typhoid and paratyphoid fever outbreaks: a worldwide review, 1990\u20132018","volume":"69","author":"Kim","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"Supplement_2","key":"10.1016\/j.ijid.2020.10.103_bib0050","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1093\/cid\/ciy1104","article-title":"A phase II, randomized, double-blind, controlled safety and immunogenicity trial of typhoid conjugate vaccine in children under 2 years of age in Ouagadougou, Burkina Faso: a methods paper","volume":"68","author":"Laurens","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.ijid.2020.10.103_bib0055","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2020.10.103_bib0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4939-9202-7_12","article-title":"Meningococcal serogroup A, B, C, W, X, and Y serum bactericidal antibody assays","volume":"1969","author":"Lucidarme","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"Supplement_2","key":"10.1016\/j.ijid.2020.10.103_bib0065","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/cid\/ciy1103","article-title":"Typhoid Vaccine acceleration consortium Malawi: a phase iii, randomized, double-blind, controlled trial of the clinical efficacy of typhoid conjugate vaccine among children in Blantyre, Malawi","volume":"68","author":"Meiring","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2020.10.103_bib0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2020.10.103_bib0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tmaid.2008.12.006","article-title":"An outbreak of peritonitis caused by multidrug-resistant Salmonella Typhi in Kinshasa, Democratic Republic of Congo","volume":"7","author":"Muyembe-Tamfum","year":"2009","journal-title":"Travel Med Infect Dis"},{"issue":"Supplement_1","key":"10.1016\/j.ijid.2020.10.103_bib0080","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1093\/cid\/ciy878","article-title":"Introduction of Typhoid Conjugate Vaccines in Africa and Asia","volume":"68","author":"Neuzil","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ijid.2020.10.103_bib0085","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1473-3099(19)30425-6","article-title":"Typhoid Vi-conjugate vaccine for outbreak control in Zimbabwe","volume":"19","author":"Olaru","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.ijid.2020.10.103_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114702","article-title":"Descriptive epidemiology of typhoid fever during an epidemic in Harare, Zimbabwe, 2012","volume":"9","author":"Polonsky","year":"2014","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.ijid.2020.10.103_bib0095","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2020.10.103_bib0100","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1093\/cid\/ciy1107","article-title":"Assessing the impact of a Vi-polysaccharide conjugate vaccine in preventing typhoid infection among Bangladeshi children: a protocol for a phase IIIb trial","volume":"68","author":"Theiss-Nyland","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2020.10.103_bib0105","series-title":"Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials","author":"US Food and Drug Administration","year":"2007"},{"issue":"6","key":"10.1016\/j.ijid.2020.10.103_bib0110","first-page":"49","article-title":"Typhoid vaccines: WHO position paper","volume":"83","author":"World Health Organization","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ijid.2020.10.103_bib0115","series-title":"Weekly Epidemiological Record. Geneva, Switzerland","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.ijid.2020.10.103_bib0120","series-title":"Typhoid Vaccine Prequalified. Geneva, Switzerland","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.ijid.2020.10.103_bib0125","series-title":"Global Advisory Committee on Vaccine Safety","author":"World Health Organization","year":"2019"},{"issue":"2","key":"10.1016\/j.ijid.2020.10.103_bib0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018- recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220323092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220323092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:59:03Z","timestamp":1761119943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220323092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":26,"alternative-id":["S1201971220323092"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.10.103","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of co-administration of meningococcal type A and measles\u2013rubella vaccines with typhoid conjugate vaccine in children aged 15\u201323 months in Burkina Faso","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.10.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}